Please use this identifier to cite or link to this item:
Title: Significant incidence of braf p.V600E mutations in esophageal cancer sets the stage for potential use of tyrosine kinase inhibitors
Authors: Rajasooriyar, C.
Moorthy, T.
Ranatunge, N.
Ginige, A.
Surenthirakumaran, R.
Keywords: Esophageal cancer
Tyrosine kinase inhibitors
Issue Date: 2020
Publisher: Jaffna Medical Association
Citation: Proceedings JMA-September - 2020
Appears in Collections:Community & Family Medicine

Files in This Item:
File Description SizeFormat 
OP14.pdf459.2 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.